News
March 13th, 2023
Stardots reaches important milestone when clinical trials of ANLIVA kick off
Read more
February 25th, 2022
VNV Global continues to invest in Stardots
We are happy to announce that Stardots has received 10 MSEK in investments
Read moreFebruary 23rd, 2022
New Updated Graphical Profile
We have just launched our new website and graphical profile (“Dune”), including a new logotype and branded images.
Read moreJune 14th, 2021
Press release (in Swedish): VNV Global investerar i Stardots!
Stardots genomför nyemission med VNV Global som ledande investerare Uppsalaföretaget Stardots AB (”Stardots”) utvecklar en revolutionerande digital hälsoplattform för behandling av neurologiska sjukdomar med initialt…
Read moreStay up-to-date
Sign up to receive updates on our latest developments.